Review summary
Teaching objective: Recognize and treat pulmonary tuberculosis in a 23-year-old writer in Tokyo with a low income, inside Japan's public health system: seven weeks of cough, fevers, night sweats and weight loss resolved into a diagnosis by chest X-ray, three sputum specimens for acid-fast smear, Xpert MTB/RIF Ultra with rifampin resistance, liquid culture and drug susceptibility testing; HIV, hepatitis and pregnancy testing, baseline liver tests, vision testing before ethambutol, and diabetes screening; airborne precautions and immediate notification to the public health center under the Infectious Diseases Control Law; outpatient care with public funding for a smear-negative patient; the choice of the standard six-month regimen (isoniazid, rifampin, pyrazinamide and ethambutol for eight weeks, then isoniazid and rifampin for eighteen weeks) because her weight is below the 40 kg needed for the four-month rifapentine-moxifloxacin regimen; daily video-observed therapy with pyridoxine; monitoring for liver injury and optic neuropathy; a contact investigation of her household led by the public health center; treatment of moderate malnutrition and help with income; contraception counseling for rifampin interactions; and a paced plan that lets her keep writing. The modern episode is a teaching case, not a claim about her real illness or care.
Historical timeline
| Date | Event | Claims |
|---|---|---|
| May 2, 1872 | Born in Tokyo (Meiji 5, 3rd month, 25th day, in the lunisolar calendar). | CLM-0001, CLM-0002 |
| 1886 | Begins the study of classical poetry at the Haginoya. | CLM-0003 |
| summer 1889 | Her father dies; she becomes head of the household. | CLM-0004 |
| 1891 | Becomes a pupil of Nakarai Tōsui and begins to write fiction. | CLM-0005 |
| July 1893 | Opens a small shop in Shitaya Ryūsenji-chō beside the Yoshiwara; it closes in April 1894. | CLM-0006 |
| May 1894 | Moves to Hongō Maruyama-Fukuyama-chō; her major works follow. | CLM-0007, CLM-0008 |
| early 1896 | Her health declines rapidly. | CLM-0010 |
| November 23, 1896 | Dies of tuberculosis at home in Hongō, at 24. | CLM-0011, CLM-0009 |
| November 1, 2004 | Her portrait appears on the new 5,000-yen note. | CLM-0012 |
Evidence claims
D = documented, R = retrospective, S = synthetic.
| Grade | Claim | Certainty | Sources |
|---|---|---|---|
| D | Higuchi Ichiyō, whose given name was Natsu (also written Natsuko), was born in Tokyo on the 25th day of the 3rd month of Meiji 5 in the Japanese lunisolar calendar, which is 2 May 1872 in the Gregorian calendar, in official housing within the grounds of the Tokyo prefectural office in Uchisaiwai-chō (now in Chiyoda). | confirmed | Portraits of Modern Japanese Historical Figures: HIGUCHI Ichiyo supports 樋口一葉 (Higuchi Ichiyō), entries from 日本大百科全書(ニッポニカ), 世界大百科事典 and デジタル版 日本人名大辞典+Plus supports Higuchi Ichiyō (Shapers of Japanese History) supports HISTMED Master Roster v3 context |
| D | Japan replaced its lunisolar calendar with the Gregorian calendar at the end of Meiji 5: the 3rd day of the 12th month of Meiji 5 became 1 January 1873 (Meiji 6). Dates before then, including her birth, were recorded in the old calendar. Explains why her birth date is given in two calendars. |
confirmed | Calendar History 2 (The Japanese Calendar) supports |
| D | From 1886 she studied classical poetry (waka) at the Haginoya academy of Nakajima Utako. | confirmed | Portraits of Modern Japanese Historical Figures: HIGUCHI Ichiyo supports 樋口一葉 (Higuchi Ichiyō), 文京ゆかりの文人 supports |
| D | Her father died of illness in the summer of 1889, when she was 17, leaving debts from a failed business; she became head of the household and took on the support of her mother and younger sister, who did washing and needlework, and the family lived in poverty. History only; her mother and sister are given no role in the modern episode. |
confirmed | Higuchi Ichiyō (Shapers of Japanese History) supports Portraits of Modern Japanese Historical Figures: HIGUCHI Ichiyo supports Ichiyo Memorial Museum supports 樋口一葉 (Higuchi Ichiyō), entries from 日本大百科全書(ニッポニカ), 世界大百科事典 and デジタル版 日本人名大辞典+Plus supports |
| D | In 1891 she became a pupil of the novelist Nakarai Tōsui and began to write fiction, choosing to earn her living by writing at a time when this was very hard for a woman; her story Umoregi (1892) brought her into the literary world. Anchors her modern occupation as a writer. |
confirmed | Portraits of Modern Japanese Historical Figures: HIGUCHI Ichiyo supports Ichiyo Memorial Museum supports |
| D | From July 1893 to April 1894 she ran a small shop selling household goods and cheap sweets in Shitaya Ryūsenji-chō, beside the Yoshiwara pleasure quarter (now in Taitō); the shop closed after about ten months, and her life there became material for Takekurabe. History only. |
confirmed | 樋口一葉 (Higuchi Ichiyō), entries from 日本大百科全書(ニッポニカ), 世界大百科事典 and デジタル版 日本人名大辞典+Plus supports Higuchi Ichiyō (Shapers of Japanese History) supports Portraits of Modern Japanese Historical Figures: HIGUCHI Ichiyo supports Ichiyo Memorial Museum supports |
| D | In May 1894 she moved to Hongō Maruyama-Fukuyama-chō (now Nishikata, Bunkyō). Anchors the place of the index date. |
confirmed | 樋口一葉 (Higuchi Ichiyō), entries from 日本大百科全書(ニッポニカ), 世界大百科事典 and デジタル版 日本人名大辞典+Plus supports 樋口一葉 (Higuchi Ichiyō), 文京ゆかりの文人 supports |
| D | At Maruyama-Fukuyama-chō she wrote the works that made her name, among them Ōtsugomori (1894), Nigorie (1895), Takekurabe (1895 to 1896) and Jūsan'ya; Nippon.com calls the period 'the miraculous 14 months', and the Nipponica encyclopedia calls the time up to January 1896 'the miraculous year'. Anchors the modern episode's attention to her writing; the two sources measure the period differently. |
confirmed | Higuchi Ichiyō (Shapers of Japanese History) supports 樋口一葉 (Higuchi Ichiyō), entries from 日本大百科全書(ニッポニカ), 世界大百科事典 and デジタル版 日本人名大辞典+Plus supports 樋口一葉 (Higuchi Ichiyō), 文京ゆかりの文人 supports Portraits of Modern Japanese Historical Figures: HIGUCHI Ichiyo supports |
| D | She died in poverty. Anchors the low income in the modern social history. |
confirmed | Portraits of Modern Japanese Historical Figures: HIGUCHI Ichiyo supports |
| D | From the beginning of 1896 her health declined rapidly. The anchor for the index date and the presenting illness. |
confirmed | 樋口一葉 (Higuchi Ichiyō), entries from 日本大百科全書(ニッポニカ), 世界大百科事典 and デジタル版 日本人名大辞典+Plus supports |
| D | She died of tuberculosis on 23 November 1896 at her home in Hongō, at the age of 24. The National Diet Library gives the cause as lung tuberculosis; the Nipponica encyclopedia gives miliary tuberculosis. After the index date. Tuberculosis is documented; the sources differ on its form (pulmonary or miliary), so the modern pulmonary diagnosis is linked to the documented disease, not to either form. |
confirmed | Portraits of Modern Japanese Historical Figures: HIGUCHI Ichiyo supports 樋口一葉 (Higuchi Ichiyō), entries from 日本大百科全書(ニッポニカ), 世界大百科事典 and デジタル版 日本人名大辞典+Plus supports 樋口一葉 (Higuchi Ichiyō), 文京ゆかりの文人 supports Higuchi Ichiyō (Shapers of Japanese History) supports Ichiyo Memorial Museum supports |
| D | Her portrait appears on the Bank of Japan 5,000-yen note first issued on 1 November 2004, whose back shows Ogata Kōrin's painting of irises; a new 5,000-yen note with a different portrait was first issued on 3 July 2024. History only. |
confirmed | Bank of Japan Notes and Coins Currently Issued supports Higuchi Ichiyō (Shapers of Japanese History) supports Ichiyo Memorial Museum supports |
Modern synthetic problem list
| Grade | Problem | Clinical status | Verification | Placement | Historical claims |
|---|---|---|---|---|---|
| S | Cough for about seven weeks with evening fevers, night sweats, poor appetite and weight loss of about 4 kg (about 10 percent) in a woman of 23; chest X-ray with patchy right upper lobe opacities and no cavity; suspected pulmonary tuberculosis; airborne precautions and three sputum specimens for acid-fast smear, nucleic acid amplification and culture | resolved | confirmed | active | CLM-0010 |
| S | Pulmonary tuberculosis of the right upper lobe, sputum smear-negative, confirmed by Xpert MTB/RIF Ultra (Mycobacterium tuberculosis detected, low; rifampin resistance not detected) | resolved | confirmed | both_with_link | CLM-0010, CLM-0011 |
| S | Moderate protein-calorie malnutrition: BMI 17.6, about 10 percent weight loss in two months, and albumin 3.3 g/dL | resolved | confirmed | active | CLM-0004, CLM-0009 |
| S | Low and irregular income from writing, with a household to support; costs of care are a barrier | active | confirmed | active | CLM-0004, CLM-0009 |
| S | Acute uncomplicated cystitis, treated with nitrofurantoin rather than a fluoroquinolone during tuberculosis treatment; resolved | resolved | confirmed | active |
Synthetic outcome measures
| Grade | Date | Measure | Result | Coding |
|---|---|---|---|---|
| S | 1896-04-14 | Hemoglobin [Mass/volume] in Blood | 11.4 g/dL (low) Reference 12-15.5 g/dL |
http://loinc.org · 718-7 |
| S | 1896-04-14 | Leukocytes [#/volume] in Blood by Automated count | 8.6 10*3/uL Reference 4-11 10*3/uL |
http://loinc.org · 6690-2 |
| S | 1896-04-14 | Platelets [#/volume] in Blood by Automated count | 452 10*3/uL (high) Reference 150-400 10*3/uL |
http://loinc.org · 777-3 |
| S | 1896-04-14 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 12 U/L Reference 7-35 U/L |
http://loinc.org · 1742-6 |
| S | 1896-04-14 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 19 U/L Reference 10-35 U/L |
http://loinc.org · 1920-8 |
| S | 1896-04-14 | Bilirubin.total [Mass/volume] in Serum or Plasma | 0.4 mg/dL Reference 0.1-1.2 mg/dL |
http://loinc.org · 1975-2 |
| S | 1896-04-14 | Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma | 74 U/L Reference 35-104 U/L |
http://loinc.org · 6768-6 |
| S | 1896-04-14 | Albumin [Mass/volume] in Serum or Plasma | 3.3 g/dL (low) Reference 3.5-5 g/dL |
http://loinc.org · 1751-7 |
| S | 1896-04-14 | Creatinine [Mass/volume] in Serum or Plasma | 0.56 mg/dL Reference 0.5-1 mg/dL |
http://loinc.org · 2160-0 |
| S | 1896-04-14 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1891)/1.73 sq M | 131 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 1896-04-14 | Glucose [Mass/volume] in Serum or Plasma | 82 mg/dL Reference 70-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 1896-04-14 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.1% Reference Below 5.7% is normal; 6.5% or more is diabetes |
http://loinc.org · 4548-4 |
| S | 1896-04-14 | Visual acuity uncorrected Right eye by ETDRS eye chart | 85 Reference >=80 |
http://loinc.org · 79878-5 |
| S | 1896-04-14 | Visual acuity uncorrected Left eye by ETDRS eye chart | 85 Reference >=80 |
http://loinc.org · 79879-3 |
| S | 1896-04-14 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 8 | http://loinc.org · 44261-6 |
| S | 1896-04-14 | Total score [AUDIT-C] | 0 | http://loinc.org · 75626-2 |
| S | 1896-05-01 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 22 U/L Reference 7-35 U/L |
http://loinc.org · 1742-6 |
| S | 1896-05-01 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 24 U/L Reference 10-35 U/L |
http://loinc.org · 1920-8 |
| S | 1896-05-01 | Bilirubin.total [Mass/volume] in Serum or Plasma | 0.6 mg/dL Reference 0.1-1.2 mg/dL |
http://loinc.org · 1975-2 |
| S | 1896-05-01 | Visual acuity uncorrected Right eye by ETDRS eye chart | 85 Reference >=80 |
http://loinc.org · 79878-5 |
| S | 1896-05-01 | Visual acuity uncorrected Left eye by ETDRS eye chart | 84 Reference >=80 |
http://loinc.org · 79879-3 |
| S | 1896-06-12 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 26 U/L Reference 7-35 U/L |
http://loinc.org · 1742-6 |
| S | 1896-06-12 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 25 U/L Reference 10-35 U/L |
http://loinc.org · 1920-8 |
| S | 1896-06-12 | Bilirubin.total [Mass/volume] in Serum or Plasma | 0.5 mg/dL Reference 0.1-1.2 mg/dL |
http://loinc.org · 1975-2 |
| S | 1896-06-12 | Albumin [Mass/volume] in Serum or Plasma | 3.8 g/dL Reference 3.5-5 g/dL |
http://loinc.org · 1751-7 |
| S | 1896-06-12 | Hemoglobin [Mass/volume] in Blood | 12.4 g/dL Reference 12-15.5 g/dL |
http://loinc.org · 718-7 |
| S | 1896-06-12 | Visual acuity uncorrected Right eye by ETDRS eye chart | 85 Reference >=80 |
http://loinc.org · 79878-5 |
| S | 1896-06-12 | Visual acuity uncorrected Left eye by ETDRS eye chart | 85 Reference >=80 |
http://loinc.org · 79879-3 |
| S | 1896-06-12 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 5 | http://loinc.org · 44261-6 |
| S | 1896-10-20 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 18 U/L Reference 7-35 U/L |
http://loinc.org · 1742-6 |
| S | 1896-10-20 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 20 U/L Reference 10-35 U/L |
http://loinc.org · 1920-8 |
| S | 1896-10-20 | Albumin [Mass/volume] in Serum or Plasma | 4.2 g/dL Reference 3.5-5 g/dL |
http://loinc.org · 1751-7 |
| S | 1896-10-20 | Hemoglobin [Mass/volume] in Blood | 13.2 g/dL Reference 12-15.5 g/dL |
http://loinc.org · 718-7 |
| S | 1896-10-20 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 3 | http://loinc.org · 44261-6 |
| S | 1896-08-24 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | http://loinc.org · 55758-7 |
| S | 1896-08-24 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 4 | http://loinc.org · 70274-6 |
| S | 1896-08-24 | Total score [AUDIT-C] | 0 | http://loinc.org · 75626-2 |
Synthetic vital signs
| Date | Measure | Result | LOINC | Grade |
|---|---|---|---|---|
| 1896-04-14 | Body height | 148 cm | 8302-2 | S |
| 1896-04-14 | Body weight | 38.5 kg | 29463-7 | S |
| 1896-04-14 | Body mass index (BMI) [Ratio] | 17.6 kg/m2 | 39156-5 | S |
| 1896-04-14 | Systolic blood pressure | 98 mm[Hg] | 8480-6 | S |
| 1896-04-14 | Diastolic blood pressure | 62 mm[Hg] | 8462-4 | S |
| 1896-04-14 | Heart rate | 104 /min | 8867-4 | S |
| 1896-04-14 | Respiratory rate | 20 /min | 9279-1 | S |
| 1896-04-14 | Body temperature | 37.8 Cel | 8310-5 | S |
| 1896-04-14 | Oxygen saturation in Arterial blood by Pulse oximetry | 96 % | 59408-5 | S |
| 1896-04-17 | Body height | 148 cm | 8302-2 | S |
| 1896-04-17 | Body weight | 38.4 kg | 29463-7 | S |
| 1896-04-17 | Body mass index (BMI) [Ratio] | 17.5 kg/m2 | 39156-5 | S |
| 1896-04-17 | Systolic blood pressure | 96 mm[Hg] | 8480-6 | S |
| 1896-04-17 | Diastolic blood pressure | 60 mm[Hg] | 8462-4 | S |
| 1896-04-17 | Heart rate | 100 /min | 8867-4 | S |
| 1896-04-17 | Respiratory rate | 20 /min | 9279-1 | S |
| 1896-04-17 | Body temperature | 37.6 Cel | 8310-5 | S |
| 1896-04-17 | Oxygen saturation in Arterial blood by Pulse oximetry | 96 % | 59408-5 | S |
| 1896-05-01 | Body height | 148 cm | 8302-2 | S |
| 1896-05-01 | Body weight | 39.2 kg | 29463-7 | S |
| 1896-05-01 | Body mass index (BMI) [Ratio] | 17.9 kg/m2 | 39156-5 | S |
| 1896-05-01 | Systolic blood pressure | 100 mm[Hg] | 8480-6 | S |
| 1896-05-01 | Diastolic blood pressure | 62 mm[Hg] | 8462-4 | S |
| 1896-05-01 | Heart rate | 90 /min | 8867-4 | S |
| 1896-05-01 | Respiratory rate | 18 /min | 9279-1 | S |
| 1896-05-01 | Body temperature | 37.1 Cel | 8310-5 | S |
| 1896-05-01 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 % | 59408-5 | S |
| 1896-06-12 | Body height | 148 cm | 8302-2 | S |
| 1896-06-12 | Body weight | 41 kg | 29463-7 | S |
| 1896-06-12 | Body mass index (BMI) [Ratio] | 18.7 kg/m2 | 39156-5 | S |
| 1896-06-12 | Systolic blood pressure | 102 mm[Hg] | 8480-6 | S |
| 1896-06-12 | Diastolic blood pressure | 64 mm[Hg] | 8462-4 | S |
| 1896-06-12 | Heart rate | 80 /min | 8867-4 | S |
| 1896-06-12 | Respiratory rate | 16 /min | 9279-1 | S |
| 1896-06-12 | Body temperature | 36.8 Cel | 8310-5 | S |
| 1896-06-12 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 1896-10-20 | Body height | 148 cm | 8302-2 | S |
| 1896-10-20 | Body weight | 44 kg | 29463-7 | S |
| 1896-10-20 | Body mass index (BMI) [Ratio] | 20.1 kg/m2 | 39156-5 | S |
| 1896-10-20 | Systolic blood pressure | 106 mm[Hg] | 8480-6 | S |
| 1896-10-20 | Diastolic blood pressure | 68 mm[Hg] | 8462-4 | S |
| 1896-10-20 | Heart rate | 72 /min | 8867-4 | S |
| 1896-10-20 | Respiratory rate | 14 /min | 9279-1 | S |
| 1896-10-20 | Body temperature | 36.5 Cel | 8310-5 | S |
| 1896-10-20 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 1896-07-20 | Body height | 148 cm | 8302-2 | S |
| 1896-07-20 | Body weight | 42 kg | 29463-7 | S |
| 1896-07-20 | Body mass index (BMI) [Ratio] | 19.2 kg/m2 | 39156-5 | S |
| 1896-07-20 | Systolic blood pressure | 104 mm[Hg] | 8480-6 | S |
| 1896-07-20 | Diastolic blood pressure | 66 mm[Hg] | 8462-4 | S |
| 1896-07-20 | Heart rate | 84 /min | 8867-4 | S |
| 1896-07-20 | Respiratory rate | 16 /min | 9279-1 | S |
| 1896-07-20 | Body temperature | 37 Cel | 8310-5 | S |
| 1896-07-20 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 1896-08-24 | Body height | 148 cm | 8302-2 | S |
| 1896-08-24 | Body weight | 42.6 kg | 29463-7 | S |
| 1896-08-24 | Body mass index (BMI) [Ratio] | 19.4 kg/m2 | 39156-5 | S |
| 1896-08-24 | Systolic blood pressure | 104 mm[Hg] | 8480-6 | S |
| 1896-08-24 | Diastolic blood pressure | 66 mm[Hg] | 8462-4 | S |
| 1896-08-24 | Heart rate | 76 /min | 8867-4 | S |
| 1896-08-24 | Respiratory rate | 14 /min | 9279-1 | S |
| 1896-08-24 | Body temperature | 36.6 Cel | 8310-5 | S |
| 1896-08-24 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
Social, functional, and mental status
Social history
- S Writer of short fiction and essays, paid by the piece by literary magazines; writes at home at a low desk, mostly at night; finished several stories in the past year and is working on new ones with editors waiting
- S Head of a household of three adults in a small rented house in Hongō, Tokyo; provides for the household from her writing income, which is low and irregular, with unpaid bills; enrolled in National Health Insurance
- S Never smoked; no alcohol (AUDIT-C 0); no drug use; no travel outside Japan; no incarceration, homelessness or work in health care; not sexually active
- S Meals irregular and small, mostly rice, pickles and tea, with fish or tofu a few times a week when money allows
- S Supports and strengths she names: her writing, her readers and editors, and the poetry she studied when young
Functional status
- S Independent; too tired over the past month to write for more than an hour or two, and short of breath on the stairs
Mental status
- S Alert, composed and precise in her answers, with a wry humor; thin and tired; organized thought
- S Mood worried about money, her household and her deadlines; PHQ-9 8, with item 9 scored 0; no thoughts of suicide or self-harm
Allergies and medications
Allergies
- S No known allergy
Medications
- S Isoniazid 100 mg tablets, two tablets (200 mg) daily
- S Rifampin (rifampicin) 150 mg capsules, three capsules (450 mg) daily
- S Pyrazinamide 500 mg tablets, two tablets (1000 mg) daily
- S Ethambutol 100 mg tablets, six tablets (600 mg) daily
- S Vitamin B6 (pyridoxine) 50 mg tablet, one tablet daily
- S Nitrofurantoin monohydrate/macrocrystals 100 mg oral capsule, one capsule twice daily with food for five days
Procedures and immunizations
Procedures
- S Chest X-ray, two views: patchy opacities in the apical and posterior segments of the right upper lobe with small nodules; no cavity, effusion or hilar enlargement
- S Chest X-ray, two views, at the end of treatment: right upper lobe opacities cleared, leaving a few linear scars; kept as the baseline for any future comparison
- S Cervical cytology (Papanicolaou test), first screening
- S Advance care planning conversation, about 16 minutes
Immunizations
- S 1896-08-24: Tetanus, diphtheria, and acellular pertussis vaccine (Tdap)
- S 1896-08-24: Hepatitis B vaccine (HepB-CpG), dose 1 of 2
- S 1896-08-24: Human papillomavirus 9-valent vaccine, dose 1 of 3
- S 1896-10-20: Hepatitis B vaccine (HepB-CpG), dose 2 of 2
- S 1896-10-20: Human papillomavirus 9-valent vaccine, dose 2 of 3
- S 1896-10-20: Influenza vaccine, inactivated, trivalent, preservative-free
Past medical history
True biography with historical dates; not part of the synthetic care timeline.
Family history
- D father: Died of illness in 1889; cause not recorded in the cited source
Care-plan goals
| Goal | Target date | Status | Outcome |
|---|---|---|---|
| Complete 182 daily doses within about six and a half months by video-observed therapy | 1896-10-20 | completed | All 182 doses completed in 26 weeks: 56 in the intensive phase and 126 in the continuation phase, none missed |
| Sputum culture negative at two months | 1896-10-20 | completed | The cultures taken at two weeks and at two months both showed no growth after six weeks |
| Weight at least 44 kg (BMI about 20) by the end of treatment | 1896-10-20 | completed | 44.0 kg at the end of treatment, from 38.5 kg at intake |
| Keep writing on a paced schedule without losing income during treatment | 1896-10-20 | completed | Public funding covered most treatment costs; she kept writing about two hours a day and finished new work |
| No drug-induced liver injury or loss of vision during treatment | 1896-10-20 | completed | Liver tests normal throughout; visual acuity unchanged |
Interventions
| Intervention | Status | Guideline |
|---|---|---|
| Diagnosis and safety: chest X-ray; three sputum specimens at least eight hours apart, one early in the morning, for acid-fast smear, Xpert MTB/RIF Ultra, liquid and solid culture and drug susceptibility testing; HIV, hepatitis B and hepatitis C tests and a pregnancy test; blood count, liver and kidney tests, glucose and hemoglobin A1c; visual acuity and color vision before ethambutol | completed | GL-ATS-TBDX-2017, GL-ATS-TB-2016, GL-WHO-TB-2022 |
| Infectious diseases consultation at the results visit to confirm the diagnosis, choose between the six-month and four-month regimens, set the doses for her weight, and plan monitoring and infection control | completed | GL-ATS-TB-2016, GL-ATS-TB-2025, GL-CDC-4MO-2022 |
| Infection control and public health: airborne precautions in the clinic; at home, no visitors, a surgical mask in shared rooms, windows open, and sleeping in her own room until the public health center confirms she is no longer infectious; report of suspected tuberculosis to the public health center the same day and notification at once on diagnosis; a contact investigation of her household and other close contacts led by the public health center | completed | GL-MHLW-TB-NOTIFY, GL-CDC-CONTACT-2005, GL-ATS-TB-2016 |
| Nutrition, income and writing: two dietitian visits in the first month, three meals and two energy-dense snacks a day with two oral nutrition supplement drinks, and weight at every visit; a medical social worker to apply for public funding of tuberculosis treatment and to review other help with costs; a paced writing plan of short sessions in daylight with rest; PHQ-9 at intake, at two months and at the end of treatment | completed | GL-ASPEN-MALN-2012, GL-JP-TB-FUNDING, GL-USPSTF-DEP-2023 |
| Treatment: isoniazid 200 mg, rifampin 450 mg, pyrazinamide 1000 mg and ethambutol 600 mg daily for eight weeks, then isoniazid and rifampin daily for eighteen weeks, with pyridoxine 50 mg, by daily video-observed therapy with the public health center; ethambutol stopped once the isolate is susceptible to isoniazid and rifampin; liver tests at two weeks and monthly in the intensive phase because of her low weight and albumin; visual acuity and color vision monthly while on ethambutol; sputum smear and culture at two weeks and two months; chest X-ray at the end of treatment | completed | GL-ATS-TB-2016, GL-ATS-TB-2025, GL-WHO-TB-2022, GL-ATS-HEPATOTOX-2006 |
| Acute cystitis: nitrofurantoin 100 mg twice daily for five days with urine culture; no fluoroquinolone, because these drugs are kept for drug-resistant tuberculosis and can blur the picture of tuberculosis; continue every tuberculosis dose; plenty of fluids; return for fever, flank pain, vomiting or symptoms that are not better in two days | completed | GL-IDSA-UTI-2010, GL-ATS-TB-2016 |
| Prevention: cervical cytology now and every three years; Tdap; hepatitis B vaccine in two doses and HPV vaccine in three doses; influenza vaccine in the autumn; folic acid 0.4 mg daily advised; contraception counseling that rifampin makes hormonal pills, patches, rings and implants unreliable, with a copper IUD, injectable progestin or condoms as reliable choices if she needs contraception during treatment | completed | GL-USPSTF-CERV-2018, GL-CDC-IMZ-2026, GL-CDC-SPR-2024, GL-USPSTF-FOLIC-2023 |
Planned encounters
- 1896-04-14 — New patient visit for seven weeks of cough, fevers, night sweats and weight loss: chest X-ray, sputum specimens, blood tests, airborne precautions, and a report of suspected tuberculosis to the public health center (ENC-001)
- 1896-04-17 — Results visit: pulmonary tuberculosis confirmed; infectious diseases consultation and the start of the standard six-month regimen (ENC-002)
- 1896-05-01 — Two-week review on treatment: culture result, liver tests, vision, and release from precautions (ENC-003)
- 1896-06-12 — End of the eight-week intensive phase: susceptibility results, the two-month sputum culture, and the start of the continuation phase (ENC-004)
- 1896-07-20 — Same-day sick visit for acute cystitis during tuberculosis treatment (ENC-006, unscheduled)
- 1896-08-24 — Periodic adult preventive visit (ENC-007)
- 1896-10-20 — End-of-treatment review after 182 doses (ENC-005)
Supporting documents
- History and physical
- Progress note 01
- Progress note 02 — Focused Visit (Follow-up)
- Progress note 03 — Focused Visit (Follow-up)
- Progress note 04 — Focused Visit (Follow-up)
- Progress note 05 — Sick Visit
- Progress note 06 — Preventive Visit
- Progress note 07 — Focused Visit (Care-plan review)
- Infectious Diseases (tuberculosis) referral
- Infectious Diseases (tuberculosis) consultation
- Patient care plan
- Teaching note
- Provenance CSV
C-CDA note documents
Each link opens a readable copy; the XML beside it is the exchange file.
- History and physical (XML)
- Progress note 01 (XML)
- Progress note 02 — Focused Visit (Follow-up) (XML)
- Progress note 03 — Focused Visit (Follow-up) (XML)
- Progress note 04 — Focused Visit (Follow-up) (XML)
- Progress note 05 — Sick Visit (XML)
- Progress note 06 — Preventive Visit (XML)
- Progress note 07 — Focused Visit (Care-plan review) (XML)
- Infectious Diseases (tuberculosis) referral (XML)
- Infectious Diseases (tuberculosis) consultation (XML)
Sources
| ID | Source | Publisher | Type |
|---|---|---|---|
| SRC-0001 | Portraits of Modern Japanese Historical Figures: HIGUCHI Ichiyo | National Diet Library, Japan | biography |
| SRC-0002 | 樋口一葉 (Higuchi Ichiyō), entries from 日本大百科全書(ニッポニカ), 世界大百科事典 and デジタル版 日本人名大辞典+Plus | Kotobank (Asahi Shimbun), carrying Shogakukan, Heibonsha and Kodansha reference works | scholarly |
| SRC-0003 | Higuchi Ichiyō (Shapers of Japanese History) | Nippon.com (Nippon Communications Foundation) | biography |
| SRC-0004 | Ichiyo Memorial Museum | Taito City Culture Foundation (Ichiyō Memorial Museum, Taitō, Tokyo) | biography |
| SRC-0005 | Bank of Japan Notes and Coins Currently Issued | Bank of Japan | other |
| SRC-0006 | Calendar History 2 (The Japanese Calendar) | National Diet Library, Japan | scholarly |
| SRC-0007 | 樋口一葉 (Higuchi Ichiyō), 文京ゆかりの文人 | Bunkyō City, Tokyo | biography |
| SRC-0009 | HISTMED Master Roster v3 | The Human Record project | other |
Review status
| Review | Status | Notes |
|---|---|---|
| schema validation | not_started | Run scripts/build.ps1 -Conformance. |
| clinical review | not_started | Awaiting clinician review; check outpatient care for smear-negative, Xpert-positive disease in Japan, the six-month regimen chosen because her weight is below 40 kg, the weight-based doses, liver monitoring in a malnourished woman, and the recorded gap in month-one monitoring. |
| provenance review | not_started | National Diet Library portrait biography and calendar page, Kotobank encyclopedia entries (Nipponica and others), Nippon.com, the Ichiyō Memorial Museum page, the Bunkyō City biography, and the Bank of Japan banknote page logged. Danly's biography was not read. The form of her fatal tuberculosis differs between sources (pulmonary or miliary). |
| safe messaging review | not_started | No psychiatric claim is made; PHQ-9 at most 8 with item 9 scored 0, so no safety assessment is required. Her mother and sister appear only in documented history; the household contact investigation names no one and records no result. Her death is recorded in one sentence. |
Comments and corrections
Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.
Comments appear on the online version of this page.